Figure 5From: Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal modelTumour protection experiment. Mice either naïve or vaccinated with 1, 2 and 3 doses of E7 were challenged with 1 × 105 TC-1 tumour cells and the tumour growth was monitored weekly. The percentages of mice without tumour are indicated.Back to article page